BackAcrivon Therapeutics Overview

Acrivon Therapeutics Common Stock

Latest common stock for ACRV: $42K.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$42000.00
↑ 35.48% YoYΔ $11000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Acrivon Therapeutics Common Stock History

Loading

Acrivon Therapeutics vs. peers: Common Stock Comparison

Loading

Acrivon Therapeutics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Acrivon Therapeutics (ACRV) FAQ

As of the most recent data (June 2026), ACRV shows a common stock of $42K. That compares with $31K in the prior-year period — up 35.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACRV's common stock is now $42K (was $31K) — a 35.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Acrivon Therapeutics is outperforming or lagging.

Tracking ACRV's common stock over time shows whether Acrivon Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $42K That compares with $31K in the prior-year period — up 35.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Acrivon Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $42K) with ownership activity and broader fundamentals.